Toggle Navigation

Gynuity & FIGO organize panel on postpartum hemorrhage management at ACOG 2018 Congress

American Congress of Obstetricians & Gynecologists (ACOG) Annual Clinical and Scientific Meeting 2018

April 27 – 30, 2018│Austin Convention Center │ Austin, Texas

Rethinking Postpartum Hemorrhage Management: The Role of Simple Technologies in Expanding Access to Postpartum Hemorrhage Management

April 28, 2018 │ 9:00 – 9:50am │ Room 18AB

Moderator: Paul D Blumenthal, Stanford University Medical Center

  • Beyond blood loss: Role of shock index in PPH diagnosis. Jill Durocher, Gynuity Health Projects
  • New evidence on the potential role of the simple low cost drugs misoprostol and tranexamic acid (TXA) in expanding PPH management. Beverly Winikoff, Gynuity Health Projects
  • New insights and evidence from a multi-country study on use of condom uterine balloon tamponade in PPH management. Gillian Burkhardt, Gynuity Health Projects

Presentations will be followed by a brief Q & A. Presenters will also be available after the session to demonstrate assembly of the condom-catheter uterine balloon.

The International Federation of Gynecology and Obstetrics (FIGO) is a UK-based organization that brings together professional societies of obstetricians and gynecologists from around the world. Its vision is for women to achieve the highest possible standards of physical, mental, reproductive and sexual health and wellbeing throughout their lives.

Gynuity Health Projects is a US-based research and technical assistance organization which works globally to ensure that reproductive and maternal health technologies are widely available at reasonable cost, provided in the context of high-quality services, and offered in a way that recognizes the dignity and autonomy of each individual. 

Further details about the ACOG Annual Meeting 2018 can be found here.

Gynuity staff present on postpartum hemorrhage diagnosis & management at upcoming EBCOG Congress

26th European Board & College of Obstetrics and Gynaecology (EBCOG) Congress
March 8-10, 2018 │ Palais des Congrès de Paris │ Paris, France

New Evidence and Innovations in PPH Diagnosis and Management
Friday, March 9, 2018 | 13:45 – 15:15 | Bordeaux Amphitheater

FIGO and Gynuity Health Projects invite you to join us for a scientific session that includes presentations of new evidence on PPH diagnosis and management followed by a Q&A. 
Session Chair: Prof Sir Sabaratnam Arulkumaran, past RCOG and FIGO president

Time to rethink how we diagnose and treat PPH? The role of shock index
Beverly Winikoff, President, Gynuity Health Projects

Expanding options for PPH management at all levels of care: The role of misoprostol and condom uterine balloon tamponade
Rasha Dabash, Senior Director, Gynuity Health Projects

Adding tranexamic acid (TXA) to the arsenal of interventions: The WOMAN trial results
Haleema Shakur-Still, Associate Professor, LSHTM

Full details about the EBCOG congress can be found here.

TelAbortion study featured in Cosmopolitan

Gynuity’s innovative study on telemedicine* provision of medical abortion is featured in the March 2018 issue of Cosmopolitan. The article, “Abortion’s Next Frontier: Video Chat”, is available digitally here.

The TelAbortion study evaluates the use of telemedicine for providing a medical abortion to women who may have difficulty getting to a clinic where abortion is provided. The time, travel costs, lost wages, and childcare arrangements involved in accessing this basic reproductive right can be a substantial hardship for many women in the United States. Even though millions of women have used abortion pills, and their safety is well-established, the medications are not available in pharmacies (even with a prescription) and instead must be obtained directly from providers. Through the TelAbortion study, women receive the medications by mail and are followed by their providers remotely.

For more information about this study, please visit

[*Telemedicine is the remote delivery of health care services and clinical information using a variety of telecommunications including phone, video, and the internet.]

Telabortion project referenced in Chicago Tribune

Gynuity’s innovative new study on telemedicine provision of abortion was featured in the Chicago Tribune article, entitled "On the anniversary of Roe v. Wade, a look at the future of pill-induced abortion". The study is evaluating the safety, acceptability and feasibility of the service, which aims to increase access to women who may have difficulty getting to an abortion clinic. 

For more information about this study, please visit

Gynuity Health Project’s E-news bulletin

Gynuity Health Project's E-news bulletin shares information about the work of our staff and collaborators in the field. We report on recent and upcoming meetings, highlights of new and ongoing projects, recently published articles and materials, and some of our key achievements. We will also have a "Spotlight on..." feature in each newsletter providing an in-depth look at a specific project.

Click here to view our April 2017 E-news bulletin
Click here to view our September 2017 E-news bulletin